Effectiveness of Sotrovimab in the Omicron Storm Time: A Case Series

Neutralizing monoclonal antibodies (mAbs) for pre- and post-exposure prophylaxis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are largely used to prevent the progression of the disease by blocking viral attachment, host cell entry, and infectivity. Sotrovimab, like other available...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicchitto, Gaetano, Cardillo, Lorena, Sequino, Davide, Sabatini, Paola, Adamo, Luisa, Marchitiello, Rosita, Viscardi, Maurizio, Cozzolino, Loredana, Cavallera, Antonietta, Bocchino, Marialuisa, Sanduzzi Zamparelli, Alessandro, Ferrigno, Francesco, de Carlo, Esterina, de Martinis, Claudio, Fusco, Giovanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864548/
https://www.ncbi.nlm.nih.gov/pubmed/36680143
http://dx.doi.org/10.3390/v15010102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864548/
https://www.ncbi.nlm.nih.gov/pubmed/36680143
http://dx.doi.org/10.3390/v15010102

Ejemplares similares